/
Not financial advice. Analytical data for research only.
Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.
Services-medical laboratories company · X0 · FY ends Jun · Revenue $2M · -1054.93% margin · -$24M FCF
The business is unprofitable at the operating level (-1293.49% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue declined 32.7% YoY. Margins deteriorated 52.8pp alongside, both lines moving the wrong way.
ROIC dropped from -126.08% to -246.23%, capital efficiency is deteriorating. Negative free cash flow of -$30M. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (TTM)
$2M
▼ -32.7% YoY
Net Income (TTM)
-$28M
▲ +26.6% YoY
Op. Margin
-1054.93%
▼ -52.8pp YoY
ROIC
-415.32%
▼ -120.2pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$24M
▲ +11.6% YoY
Op. Cash Flow (TTM)
-$24M
▲ +11.7% YoY
Net Debt
$3M
Cash & Equiv.
$909K
3Y CAGR: +15.4%
Continue Research
SourceComputed from the 10-Q filed 19 Nov 2024, covering the period ending 30 Sept 2024, as reported to the SEC. Data last refreshed 17 Aug 2026. How this is calculated.
Fiscal year ends Jun. Sector medians are approximate S&P 500 benchmarks and update periodically.